We’re excited to announce that Front Range Biosciences has been chosen as a finalist for the BizWest Innovation Quotient (IQ) Award! We’re in prestigious company, alongside the two other finalists of SomaLogic and Array BioPharma in the Life Sciences category.
Here is BizWest’s summary of FRB:
Front Range Biosciences — Through the process of tissue culture cloning, FRB solves the various operational problems that cultivators currently face, such as disease, inefficiency, inconsistency and scale. Tissue culture is sterile propagation of baby plants through cloning on a nutrient culture medium of known composition. Plant tissue culture is widely used to produce clones of a plant in a method known as micropropagation. Additionally, FRB’s varietal improvement program, using Next Generation Sequencing technology to create a map of cannabis genetics, helps develop commercially relevant traits in cannabis plants.
Please see the full announcement on BizWest here.